# A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With Denosumab

> **NCT00890981** · PHASE3 · COMPLETED · sponsor: **Amgen** · enrollment: 79 (actual)

## Conditions studied

- Low Bone Mass
- Low Bone Mineral Density
- Osteoporosis
- Postmenopausal Osteoporosis

## Interventions

- **PROCEDURE:** high-resolution peripheral quantitative computed tomography (HR-pQCT)
- **PROCEDURE:** Dual energy X-ray absorptiometry (DXA)
- **BIOLOGICAL:** Denosumab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00890981
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-06
- **Final completion:** 2010-08
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2014-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00890981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00890981, "A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With Denosumab". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00890981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*